Eastgate Biotech Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Rose Perri
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.8yrs |
| CEO ownership | n/a |
| Management average tenure | 7.8yrs |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
CEO
Rose Perri (55 yo)
7.8yrs
Tenure
Ms. Rosella C. Perri, also known as Rose serves as Chief Executive Officer of Eastgate Biotech Corp. since August 2020 and has been its Secretary and Treasurer since June 2016 and serves as its Director. M...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Secretary | 7.8yrs | no data | no data | |
| Vice Chairman | 4.8yrs | no data | no data | |
| Chief Scientific Officer | 12yrs | US$285.85k | no data |
7.8yrs
Average Tenure
65yo
Average Age
Experienced Management: ETBI's management team is seasoned and experienced (7.8 years average tenure).